The pulmonary artery in COPD - Does size matter?

New England Journal of Medicine

Volumn 367, Issue 10, 2012, Pages 946-948

  Stanbrook, Matthew B ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MACROLIDE; PHOSPHODIESTERASE IV INHIBITOR;

ARTERIAL GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; EDITORIAL; EMPHYSEMA; HEART LEFT VENTRICLE FAILURE; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RISK ASSESSMENT; RISK REDUCTION; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

EID: 84865695699     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1209376     Document Type: Editorial

References (9)

1. Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012. DOI: 10.1056/NEJMoa1203830.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD (revised 2011) (http://www.goldcopd.org/).
3. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158-64. (Pubitemid 29036519)
4. Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 2006;173:736-43.
5. Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol 2011;163:53-67.
6. Yamaya M, Azuma A, Takizawa H, Kadota J, Tamaoki J, Kudoh S. Macrolide effects on the prevention of COPD exacerbations. Eur Respir J 2012;40:485-94.
7. Peinado VI, Barberá JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1605-11. (Pubitemid 29227877)
8. Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006;130:326-33. (Pubitemid 44266997)
9. Keller CA, Shepard JW Jr, Chun DS, Vasquez P, Dolan GF. Pulmonary hypertension in chronic obstructive pulmonary disease: multivariate analysis. Chest 1986;90:185-92. (Pubitemid 16040567)